These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11685041)

  • 1. Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.
    Tacke F; Schöffski P; Trautwein C; Manns MP; Ganser A; von Depka M
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):539-45. PubMed ID: 11685041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.
    Borawski J; Naumnik B; Mysliwiec M
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):359-67. PubMed ID: 12516686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
    Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
    Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
    Zermatten MG; Fraga M; Calderara DB; Aliotta A; Moradpour D; Alberio L
    JHEP Rep; 2020 Aug; 2(4):100120. PubMed ID: 32715285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis.
    Van Thiel DH; Farr DE; Mindikoglu AL; Todo A; George MM
    J Gastroenterol Hepatol; 2005 Jun; 20(6):882-9. PubMed ID: 15946135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
    Tripodi A; Salerno F; Chantarangkul V; Clerici M; Cazzaniga M; Primignani M; Mannuccio Mannucci P
    Hepatology; 2005 Mar; 41(3):553-8. PubMed ID: 15726661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin conversion and thrombin decay in patients with cirrhosis-role of prothrombin and antithrombin deficiencies.
    Sinegre T; Abergel A; Lecompte T; Lebreton A
    J Thromb Haemost; 2024 May; 22(5):1347-1357. PubMed ID: 38309434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
    Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
    Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low sensibility to the action of thrombomodulin in cirrhotic patients. Interest of thrombinography].
    Sinegre T; Abergel A; Sapin AF; Lamblin G; Marques-Verdier A; Duron C; Lebreton A
    Ann Biol Clin (Paris); 2016; 74(2):203-12. PubMed ID: 26806287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
    Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena.
    Ruberto MF; Sorbello O; Civolani A; Barcellona D; Demelia L; Marongiu F
    Int J Lab Hematol; 2017 Aug; 39(4):369-374. PubMed ID: 28422416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats.
    Mohri M; Oka M; Aoki Y; Gonda Y; Hirata S; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T
    Am J Hematol; 1994 Apr; 45(4):298-303. PubMed ID: 8178801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding time in patients with hepatic cirrhosis.
    Blake JC; Sprengers D; Grech P; McCormick PA; McIntyre N; Burroughs AK
    BMJ; 1990 Jul; 301(6742):12-5. PubMed ID: 2383699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
    Lisman T; Bakhtiari K; Pereboom IT; Hendriks HG; Meijers JC; Porte RJ
    J Hepatol; 2010 Mar; 52(3):355-61. PubMed ID: 20132999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
    La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
    Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
    Potze W; Adelmeijer J; Porte RJ; Lisman T
    Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
    Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
    J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.